Insulin-like Growth Factor-2 Binding Protein-2 Gene Polymorphisms in Iraqi Patients with Type 2 Diabetes Mellitus


  • Zubaida Falih Department of Clinical Laboratory Sciences, Faculty of Pharmacy, University of Kufa, Kufa, Iraq
  • Bayadir Ali Wannas Khodair Department of Physiology, Faculty of Veterinary Medicine, University of Kufa, Kufa, Iraq
  • Noaman Ibadi Mohammed Department of Physiology, Faculty of Veterinary Medicine, University of Kufa, Kufa, Iraq
  • Tahseen Kadhem Mohammed Department of Clinical Laboratory Sciences, Faculty of Pharmacy, University of Kufa, Kufa, Iraq



Polymorphism, T2DM, IGF2BP2 gene, RFLP-PCR


Background: Diabetes mellitus type2 (T2DM) represent a hyperglycemia causing metabolic disease which exists in the peripheral tissues due to incomplete pancreatic insulin secretion or insulin resistance. IGF2BP2 is a protein that is involved in embryogenesis and pancreatic development. Genetic association researches had suggested that the single nucleotide polymorphisms (SNP) spanning IGF2BP2 gene are associated with the progression as well as development of the T2DM.

Aim: This study aims to evaluate the association of IGF2BP2 gene polymorphisms (rs4402960 & rs1470579) with T2DM in a sample of Iraqi individuals.

Methods: A case-control study has been conducted on 800 participants, they were divided to two equal groups, which are a healthy control group (400) and type 2 diabetic patients (400). Fast blood sugar (FBS), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and HbA1c] measured suitable for both participant groups. IGF2BP2 gene has been genotyped for polymorphisms; rs4402960 and rs1470579 by using the PCR-RFLP technique.

Results: There is significant changes in the biochemical parameters in patients group when compared to the control group.The SNP rs4402960 show minor allele frequency of T allele considerably different between the two participating groups (p 0.0013) with 33.6 % in T2DM group. Homo-variant TT shows a significant p <0.0001) odd ratio (4.5) as codominant type. Similarly, dominant and recessive models exert significant (0.02 & <0.0001 respectively) adjusted odd ratio (1.45 & 4.14 respectively). The rs1470579 SNP show a significant (0.024) risk (1.28) of C allele in the patients group than in A allele. The CC genotype in codominant and recessive models show significant (0.03) odd ratio differences (2.03 & 1.96 respectively. The rs1470579 SNP exerts significant differences as codominant model in biochemical features of BMI, FBG, Tgs, VLDL-C, insulin and HOMA-IR. The study power of rs4402960 is 69.5% and rs1470579 is 34.1%.

Conclusion: This study confirmed the association of rs4402960 as codominant, dominant and recessive with T2DM significantly. However, rs1470579 is associate as recessive model with T2DM in Iraqi population. 


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Wondmkun YT. Obesity, insulin resistance, and type 2 diabetes: Associations and therapeutic implications. Diabetes Metab Syndr Obes. 2020;13:3611-6. PMid:33116712 DOI:

Cheng F, Liu L, Zhang H, Zhu Y, Li X, Li H. Association of IL-16 gene polymorphisms with the risk of developing type 2 diabetes mellitus in the Chinese Han population. Biosci Rep. 2019;39(8):BSR20190821. PMid:31375554 DOI:

Christiansen J, Kolte AM, Hansen TV, Nielsen FC. IGF2 mRNA-binding protein 2: Biological function and putative role in type 2 diabetes. J Mol Endocrinol. 2009;43(5):187-95. PMid:19429674 DOI:

Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999;19(2):1262-70. PMid:9891060 DOI:

Zhang JY, Chan EK, Peng XX, Tan EM. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med. 1999;189(7):1101-10. PMid:10190901 DOI:

Cao J, Yan W, Ma X, Huang H, Yan H. Insulin-like growth factor 2 mRNA-binding protein 2-a potential link between type 2 diabetes mellitus and cancer. J Clin Endocrinol Metab. 2021;106(10):2807-18. PMid:34061963 DOI:

Cao J, Mu Q, Huang H. The roles of insulin-like growth factor 2 mRNA-binding protein 2 in cancer and cancer stem cells. Stem Cells Int. 2018;2018:4217259. PMid:29736175 DOI:

Yaniv K, Yisraeli JK. The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis. Gene. 2002;287(1-2):49-54. PMid:11992722 DOI:

Boudoukha S, Cuvellier S, Polesskaya A. Role of the RNA-binding protein IMP-2 in muscle cell motility. Mol Cell Biol. 2010;30(24):5710-25. PMid:20956565 DOI:

Esparza-Moltó PB, Cuezva JM. Reprogramming oxidative phosphorylation in cancer: A role for rna-binding proteins. Antioxidants Redox Signal. 2020;33(13):927-45. PMid:31910046 DOI:

Janiszewska M, Suvà M, Riggi N, Houtkooper R, Auwerx J, Clément-Schatlo V, et al. Imp2 controls oxidative phosphorylation and is crucial for preservin glioblastoma cancer stem cells. Genes Dev. 2012;26(17):1926-44. PMid:22899010 DOI:

Dai N, Zhao L, Wrighting D, Krämer D, Majithia A, Wang Y, et al. IGF2BP2/IMP2-deficient mice resist obesity through enhanced translation of Ucp1 mRNA and other mRNAs encoding mitochondrial proteins. Cell Metab. 2015;21(4):609-21. PMid:25863250 DOI:

Sanghera D, Ortega L, Han S, Singh J, Ralhan S, Wander G, et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 2008;9:1-9. PMid:18598350 DOI:

Stancáková A, Kuulasmaa T, Paananen J, Jackson AU, Bonnycastle LL, Collins FS, et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes. 2009;58(9):2129-36. PMid:19502414 DOI:

Mohammed A, Nagwan A, Amany Y, Fathalla M, Abdelraouf M. Insulin-like growth factor 2 binding protein 2 gene polymorphism in Egyptian patients with type 2 diabetes. Egypt J Biochem Mol Biol. 2018;36(1-2):35-48. DOI:

Tarnowski M, Bujak J, Kopytko P, Majcher S, Ustianowski P, Dziedziejko V, et al. Effect of FTO and IGF2BP2 gene polymorphisms on duration of pregnancy and Apgar scores in women with gestational diabetes. J Obstet Gynaecol. 2019;39(2):151-6. PMid:30371117 DOI:

Chang YC, Liu PH, Yu YH, Kuo SS, Chang TJ, Jiang YD, et al. Validation of type 2 diabetes risk variants identified by genome-wide association studies in han chinese population: A replication study and meta-analysis. PLoS One. 2014;9(4):e95045. PMid:24736664 DOI:

Lasram K, Ben Halim N, Benrahma H, Mediene-Benchekor S, Arfa I, Hsouna S, et al. Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population. J Diabetes. 2015;7(1):102-13. PMid:24636221 DOI:

Al-Sinani S. Association of gene variants with susceptibility to type 2 diabetes among Omanis. World J Diabete. 2015;6(2):358-66. PMid:25789119 DOI:

Wu J, Wu J, Zhou Y, Zou H, Guo S, Liu J, et al. Quantitative assessment of the variation in IGF2BP2 gene and type 2 diabetes risk. Acta Diabetol. 2012;49 Suppl 1:S87-97. PMid:22015911 DOI:

American Diabetes Association. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43 Suppl 1:S14-31. PMid:31862745 DOI:

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. PMid:3899825 DOI:

Lee YH. An overview of meta-analysis for clinicians. Korean J Intern Med. 2018;33(2):277-83. PMid:29277096 DOI:

Rao P, Wang H, Fang H, Gao Q, Zhang J, Song M, et al. Association between IGF2BP2 polymorphisms and type 2 diabetes mellitus: A case-control study and meta-analysis. Int J Environ Res Public Health. 2016;13(6):574. PMid:27294943 DOI:

Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y, Yamagata K. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab. 2008;93(8):3136-41. PMid:18477659 DOI:

Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, Miki T, et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes. 2009;58(2):493-8. PMid:19033397 DOI:

Sargazi S, Heidari Nia M, Saravani R, Jafari Shahroudi M, Jahantigh D, Shakiba M. IGF2BP2 polymorphisms as genetic biomarkers for either schizophrenia or type 2 diabetes mellitus: A case-control study. Gene Rep. 2020;20(3):100680. DOI:

Ali W. Association of common variants in the IGF2BP2 gene with type 2 diabetes. Sohag Med J. 2021;25(2):62-9. DOI:

Wu Y, Li H, Loos R, Yu Z, Ye X, Chen L, et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/ IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes. 2008;57(10):2834-42. PMid:18633108 DOI:

Huang Q, Yin JY, Dai XP, Pei Q, Dong M, Zhou ZG, et al. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population. Acta Pharmacol Sin. 2010;31(6):709-17. PMid:20523342 DOI:

Greenwald W, Chiou J, Yan J, Qiu Y, Dai N, Wang A, et al. Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk. Nat Commun. 2019;10(1):2078. PMid:31064983 DOI:

Huang T, Wang L, Bai M, Zheng J, Yuan D, He Y, et al. Influence of IGF2BP2, HMG20A, and HNF1B genetic polymorphisms on the susceptibility to type 2 diabetes mellitus in Chinese Han population. Biosci Rep. 2020;40(5):BSR20193955. PMid:32329795 DOI:

Girirajan S, Campbell C, Eichler E. Bivariate Genome- Wide Association Study of Depressive Symptoms with Type 2 Diabetes and Quantitative Glycemic Traits. Physiol Behav. 2011;176(5):139-48. DOI:

Trinh I, Gluscencova OB, Boulianne GL. An in vivo screen for neuronal genes involved in obesity identifies Diacylglycerol kinase as a regulator of insulin secretion. Mol Metab. 2019;19(10):13-23. PMid:30389349 DOI:




How to Cite

Falih Z, Khodair BAW, Mohammed NI, Mohammed TK. Insulin-like Growth Factor-2 Binding Protein-2 Gene Polymorphisms in Iraqi Patients with Type 2 Diabetes Mellitus. Open Access Maced J Med Sci [Internet]. 2022 May 21 [cited 2023 Mar. 28];10(A):1178-83. Available from: